Italian study demonstrates utility of Woundchek’s wound diagnostic tests.

Date: Sep 15, 2022

Professor Claudio Ligresti led a study in four Italian wound clinics where forty chronic ulcers were treated with the therapy decisions assisted by WOUNDCHEK™ Bacterial Status and WOUNDCHEK™ Protease Status tests.

Testing was repeated and outcomes monitored after approximately fifteen and thirty days. The outcomes and treatments employed were compared with a cohort that were not tested. Using the two point of care test results to inform treatment decisions was strongly associated with increased rates of healing and improvement.

Professor Ligresti found that the rapid test results were extremely valuable in selecting treatments and monitoring effectiveness and especially useful in targeted use of advanced therapies and invasive surgical interventions.

The study confirmed that using WOUNDCHEK™ Bacterial Status and WOUNDCHEK™ Protease Status tests can assist treatment decisions and improve healing.